Genetic heterogeneity in the apolipoprotein C-III promoter and effects of insulin
In the present study, we have investigated the in vivo and in vitro role of two newly identified variants (G−944A and A−1180C) located in the upstream promoter region of the apolipoprotein C-III (apoC-III) gene. These variants were studied in 30 probands diagnosed with FCHL, their relatives, and spo...
Main Authors: | Geesje M. Dallinga-Thie, Martine Groenendijk, Richard N.H.H.C. Blom, Tjerk W.A. De Bruin, Eric De Kant |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2001-09-01
|
Series: | Journal of Lipid Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227520302789 |
Similar Items
-
Familial combined hyperlipidemia plasma stimulates protein secretion by HepG2 cells
by: Marleen M.J. van Greevenbroek, et al.
Published: (2002-11-01) -
Association of plasma lipids and apolipoproteins with the insulin response element in the apoC-III promoter region in familial combined hyperlipidemia
by: M. Groenendijk, et al.
Published: (1999-06-01) -
Human Cytotoxicity, Hemolytic Activity, Anti-Inflammatory Activity and Aqueous Solubility of Ibuprofen-Based Ionic Liquids
by: Joana C. Bastos, et al.
Published: (2022-08-01) -
Pitavastatin-loaded bilosomes for oral treatment of hepatocellular carcinoma: a repurposing approach
by: Maged Kharouba, et al.
Published: (2022-12-01) -
Simvastatin ameliorates oxidative stress levels in HepG2 cells and hyperlipidemic rats
by: Kanika Verma, et al.
Published: (2022-01-01)